NCT02986477|WithdrawnDMC
Study Stopped
PI leaving institution
Loading search results
Sponsor study identifier
interventional
0
0 countries
N/A
Study Start
January 1, 2017
Actual (reported)Primary Completion
January 9, 2018
Actual (reported)Study Completion
January 9, 2018
Actual (reported)In children, specifically the intravesicle administration to study vesicoureteral reflux in children already catheterized and scheduled for voiding cystourethrogram (VCUG). Contrast-enhanced ultrasonography is a tremendous advancement from conventional B-mode and color Doppler ultrasonography, as it permits noninvasive, non-ionizing delineation of physiology and pathophysiology with higher resolution and accuracy in children. The technique is particularly useful in pediatric population whose lifetime risk of cancer significantly increases with higher frequency of ionizing radiation. Voiding cystourethrogram is a fluoroscopy technique that can study reflux real time but at the risk of radiation side effects. In this regard, intravesicle administration of ultrasound contrast agent can help avoid radiation in children and potentially replace the conventionally used voiding cystourethrogram.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 9, 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 5, 2016
Actual (reported)December 8, 2016
Actual (reported)January 1, 2017
Actual (reported)January 9, 2018
Actual (reported)January 9, 2018
Actual (reported)Clinical Applications of Contrast-Enhanced Ultrasonography in Pediatric Population - Intravesicle Administration
The presence of vesicoureteral reflux is assessed as the primary outcome measure. Qualitative evaluation is performed to assess the presence of contrast within the collecting systems, which then correlates with vesicoureteral reflux. Since this is a qualitative evaluation based on the acquired radiologic images, there is no unit, but the degree of vesicoureteral reflux is assessed. Vesicoureteral reflux is graded into I to V grades based on the severity.
10 years
Patients with vesicoureteral reflux will receive contrast ultrasound via Foley catheter for study of vesicoureteral reflux.
For diagnostic purposes, intravesicle administration of contrast ultrasound agent will be performed to study vesicoureteral reflux.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
0 participants (actual enrollment reported by the registry).
First Submitted
December 5, 2016
First Posted
December 8, 2016
Study Start
January 1, 2017
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
January 9, 2018
Actual (reported)Study Completion
January 9, 2018
Actual (reported)Last Updated
January 25, 2018
Record last verified: 2018-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: